Stock under Consideration: Northwest Biotherapeutics, Inc (NASDAQ:NWBO)

Northwest Biotherapeutics, Inc (NASDAQ:NWBO) share price plunged -9.23% or -0.053 points to reach at $0.517 during previous trading session. The stock’s price fluctuated within the range of $91 – $99 during previous trading session. A total of 7,935,240 shares exchanged hands, whereas the company’s average trading volume stands at 1.83M shares. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) has a market capitalization of $83.92M and most recently 113.74M outstanding shares have been calculated.

Relative strength index (RSI-14) for Northwest Biotherapeutics, Inc (NASDAQ:NWBO) is at 67.11.

According to sentiments of 1 analysts the mean estimates of short term price target for the company’s stock is marked at $5.00. The most optimistic analyst sees the stock reaching $5.00 while the most conventional predicts the target price at $5.00.

According to sentiments of 1 analysts the company is expected to report revenues of $312.62M for the current quarter. Bearish revenue estimates established at $312.62M while the bullish revenue forecast has been figured out at $312.62M.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.00 on the shares of Northwest Biotherapeutics, Inc (NASDAQ:NWBO). Out of rating recommendations 0 have given the stock a Buy while 1 recommend the stock as Outperform. 0 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Northwest Biotherapeutics, Inc (NASDAQ:NWBO)’s distance from 20 day simple moving average is 40.55% whereas its distance from 50 day simple moving average is 21.21% along with -66.60% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) shares were trading -93.98% below from the 52-week high mark of $8.59 and +61.69% above from the 52-week bottom of $0.32. The stock hit its 52-week high price on 09/21/15, and 52-week low price on 08/26/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 51.82% in the past one week and soared 29.35% during previous one month drive, the stock went down -18.56% during past quarter. In the last six months the stock’s performance fell -61.96% while yearly performance of the company fell -93.43%. The company’s year to date (YTD) performance is at -83.83%.

While taking a glance at financials, we can look at a number of key indicators. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) has a Return on Assets (ROA) of -41.30%. The company currently has a Return on Equity (ROE) of 111.90% and a Return on Investment (ROI) of -697.70%. Average true range (ATR-14) of the company sets at 0.06, along with its weekly and monthly volatility of 25.86%, 12.96% respectively. Beta value of the stock stands at 2.10.

The company’s quick ratio for most recent quarter is 0.10 along with current ratio for most recent quarter of 0.10.